If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
305.00    0.00 (0.00%)
Bid:
300.00
Ask:
310.00
Spread: 10.00 (3.333%)
Market Cap: £38.70m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading on Sharemark

2 Apr 2009 07:00

RNS Number : 9599P
BrainJuicer Group PLC
02 April 2009
Β 

ο»Ώ

Press Release

2 April 2009

BrainJuicerΒ GroupΒ PLC

('BrainJuicer' or 'theΒ Company')

Trading on Sharemark

BrainJuicer Group PLC (AIM: BJU), a leading international online market research agency, today announces that its ordinary shares ('Shares') have been admitted to trading on Sharemark. The Shares will also continue to trade on AIM.

Sharemark is primarily aimed at private investors and is based on an order-driven trading system. The Directors believe this second trading facility will compliment the LSE's existing quote driven system and aid the liquidity of the Shares.

-Β Ends -

For further information, please contact:

Β 

BrainJuicerΒ GroupΒ PLC

John Kearon, Chief Executive Officer

Tel: +44 (0)20 7043 1000Β 

James Geddes, Chief Financial Officer

www.brainjuicer.com

Canaccord Adams Limited

Mark Williams / Adria Da BreoΒ Richards

Tel: +44 (0)20 7050 6500

www.canaccordadams.com

Sharemark

www.sharemark.com

UKΒ media enquiries:

Abchurch Communications

Tel: +44 (0) 20 7398 7700

Heather SalmondΒ /Β Jack Ballantyne

Tel: +44 (0) 20 7398 7714

jack.ballantyne@abchurch-group.comΒ 

www.abchurch-group.comΒ 

Notes to Editors

BrainJuicer carries out quantitative online research using innovative, bespoke software to produce insightful market research for large, multinational companies, includingΒ 24Β of the world's topΒ 200Β companies (FT 500 September 2008).

BrainJuicer operates in a growing sector of the US$25bn global research market, namely quantitative online research. BrainJuicer's main competitors are large traditional market research providers who have dominated the market for off-line market research, such as AC Nielsen, Millward Brown, Research International, IPSOS, GfKΒ and Taylor Nelson Sofres.

Whilst the largest traditional research companies have developed their own online capability, BrainJuicer has a number of key attributes which have contributed to it achieving rapid growth and winning contracts with prestigious clients, including:

β€’Β Research platform that delivers greater diagnostic insight.Β BrainJuicer has developed tools and award-winning techniques that enable it to provide a greater level ofΒ qualitativeΒ diagnostic insightΒ withinΒ quantitative market research. These techniques enable clients to enhance their understanding of consumer preference and help them make decisions on the best way to develop their products and services.

β€’Β Speed.Β BrainJuicer's automated research techniques enable it to conduct complicated studies very quickly. BrainJuicer's rapid deployment and results production, even on multi-country studies, provide clients with a speed to market advantage in the development of new products and services.

β€’Β A scaleable online-only business model.Β Unlike the traditional research companies who maintain both on and offline data collection capabilities, BrainJuicer is able to focus on operating a scaleable online-only business model.

To date the Group has conducted projects in over 50 countries and more than 30 languages and has establishedΒ a presenceΒ in theΒ UK,Β theΒ Netherlands,Β theΒ US,Β SwitzerlandΒ andΒ Germany.

Further information on BrainJuicer can be found atΒ www.brainjuicer.comΒ .

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCDGGGDKMNGLZM
Date   Source Headline
7th Nov 20199:29 amRNSDividend Declaration
7th Nov 20197:00 amRNSInterim Results
14th Oct 20197:00 amRNSTrading Update
5th Sep 20197:00 amRNSGrant of Options
1st Aug 20197:00 amRNSResult of AGM
28th Jun 201912:30 pmRNSAnnual Report and Notice of AGM
12th Jun 20197:00 amRNSHolding(s) in Company
6th Jun 20197:00 amRNSDividend Declaration
6th Jun 20197:00 amRNSFinancial results to 31 March 2019
18th Apr 20197:00 amRNSGrant of Options
15th Apr 20197:00 amRNSTrading Update
19th Nov 20187:00 amRNSDirector/PDMR Shareholding
6th Nov 20188:24 amRNSHolding(s) in Company
6th Nov 20187:00 amRNSPDMR Shareholding
2nd Nov 20184:08 pmRNSDividend Declaration
2nd Nov 20187:00 amRNSInterim Results
15th Oct 20187:00 amRNSTrading Update
2nd Oct 20189:09 amRNSHolding(s) in Company
28th Sep 201810:15 amRNSHolding(s) in Company
21st Sep 201811:56 amRNSDirector/PDMR Shareholding
10th Sep 20187:00 amRNSAd Ratings and Trading Update
31st Aug 20185:02 pmRNSTotal Voting Rights
20th Aug 20187:00 amRNSHolding(s) in Company
17th Aug 20182:58 pmRNSHolding(s) in Company
17th Aug 20187:00 amRNSExercise of Options
26th Jul 20187:00 amRNSDirectorate Change
25th Jul 201812:04 pmRNSResult of AGM
24th Jul 20187:00 amRNSBoard Changes
10th Jul 20189:12 amRNSHolding(s) in Company
9th Jul 201811:31 amRNSHolding(s) in Company
2nd Jul 20183:50 pmRNSAnnual Report and Notice of AGM
28th Jun 20185:57 pmRNSHolding(s) in Company
12th Jun 20187:00 amRNSExercise of Options
11th Jun 20187:00 amRNSBoard Change
5th Jun 20184:31 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSDirector/PDMR Shareholding
4th Jun 20183:10 pmRNSDividend Declaration
1st Jun 20187:00 amRNSFinancial results to 31 March 2018
23rd May 20188:26 amRNSHolding(s) in Company
27th Apr 20184:30 pmRNSHolding(s) in Company
18th Apr 20187:00 amRNSTrading Update
9th Mar 20183:30 pmRNSTransaction in Own Shares
9th Mar 20187:00 amRNSExercise of Options and Buyback of Option Shares
8th Jan 20187:00 amRNSTrading Update
28th Nov 201711:52 amRNSHolding(s) in Company
27th Nov 20179:48 amRNSHolding(s) in Company
17th Nov 20177:00 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSInterim Results
16th Oct 20177:00 amRNSTrading Update
2nd Oct 20174:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.